Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
01548 GENSCRIPT BIO
RTNominal up14.500 +0.300 (+2.113%)
Others

30/12/2019 10:26

Genscript Bio (01548) signs investment agreement

[ET Net News Agency, 30 December 2019] Genscript Biotech Corporation (01548) said its
subsidiary GenScript (Hong Kong) Limited (GS HK) has entered into an investment agreement
with Zhenjiang New Area Management Committee (the Zhenjiang Committee).
Zhenjiang Committee shall provide Genscript HK with three factories of 20,000m2 in total
at nil rent for five years (from 2021 to 2025). GS HK will invest a total of RMB180
million by contributing fixed assets and cash for the construction of factories, office
buildings and other storage facilities for the expansion of (i) the molecular biology
production capacity, (ii) the research laboratory of cell therapy vector plasmid
technology, and (iii) peptide GMP (good manufacturing practices) business. (RC)

Remark: Real time quote last updated: 28/03/2024 18:00
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.